{Reference Type}: Journal Article
{Title}: LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review.
{Author}: Khalilollah S;Kalantari Soltanieh S;Obaid Saleh R;Ali Alzahrani A;Ghaleb Maabreh H;Mazin Al-Hamdani M;Dehghani-Ghorbi M;Shafiei Khonachaei M;Akhavan-Sigari R;
{Journal}: Cytokine
{Volume}: 179
{Issue}: 0
{Year}: 2024 07 4
{Factor}: 3.926
{DOI}: 10.1016/j.cyto.2024.156585
{Abstract}: The pathophysiology of several illnesses, including cancer and autoimmune diseasesdepends on human regulatory T cells (Tregs), and abnormalities in these cells may function as triggers for these conditions. Cancer and autoimmune, and gynecological diseases are associated with the differentiation of the proinflammatory T cell subset TH17 and its balance with the production of Treg. Recently, long non-coding RNAs (lncRNAs) have become important regulatory molecules in a wide range of illnesses. During epigenetic regulation, they can control the expression of important genes at several levels by affecting transcription, post-transcriptional actions, translation, and protein modification. They might connect with different molecules, such as proteins, DNA and RNA, and their structural composition is intricate. Because lncRNAs regulatebiological processes, including cell division, death, and growth, they are linked to severaldiseases. A notable instance of this is the lncRNA NEAT1, which has been the subject of several investigations to ascertain its function in immune cell development. In the context of immune cell development, several additional lncRNAs have been connected to Treg cell differentiation. In this work, we summarize current findings about the diverse functions of lncRNAs in Treg cell differentiation and control of the Th17/Treg homeostasis in autoimmune disorders, cancers, as well as several gynecological diseases where Tregs are key players.